(Total Views: 737)
Posted On: 04/18/2019 8:24:35 AM
Post# of 1088
$CBDL
COTTSDALE, ARIZONA, April 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC:CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience has entered into negotiations to distribute its line of products in Japan. The negotiations are anticipated to close within the next two weeks with an initial order of $250,000.
Japan’s market for CBD products is growing at almost 100% year-over-year with annual supplement sales valued at over $10 billion. Japan's consumer economy is very health conscious, sophisticated, comprised of an aging population with an early adoption of CBD nutraceuticals.
“We are very excited about this opportunity to enter the Japanese market,” commented Lisa Nelson, President & CEO of CBD Life Science. “The Japanese have embraced the benefits of CBD and we want to be on the forefront providing quality products to this aggressive expanding market,” continued Ms. Nelson.
About CBD Life Sciences Inc.
CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol ‘CBDL’. The Company’s main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the company is actively searching for additional opportunities within this emerging sector.
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions, supplements, edibles, and a full line of pet products. In addition, LBC is in the process of developing an anti-aging skin product line. LBC’s products can be viewed and purchased on the company’s website at www.lbcbioscienceinc.com.
Contact Information
Investor Relations
Ten Associates LLC
11529 N. 120th St.
Scottsdale, Arizona
85259 USA
Telephone: 480-326-8577
COTTSDALE, ARIZONA, April 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC:CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience has entered into negotiations to distribute its line of products in Japan. The negotiations are anticipated to close within the next two weeks with an initial order of $250,000.
Japan’s market for CBD products is growing at almost 100% year-over-year with annual supplement sales valued at over $10 billion. Japan's consumer economy is very health conscious, sophisticated, comprised of an aging population with an early adoption of CBD nutraceuticals.
“We are very excited about this opportunity to enter the Japanese market,” commented Lisa Nelson, President & CEO of CBD Life Science. “The Japanese have embraced the benefits of CBD and we want to be on the forefront providing quality products to this aggressive expanding market,” continued Ms. Nelson.
About CBD Life Sciences Inc.
CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol ‘CBDL’. The Company’s main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the company is actively searching for additional opportunities within this emerging sector.
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions, supplements, edibles, and a full line of pet products. In addition, LBC is in the process of developing an anti-aging skin product line. LBC’s products can be viewed and purchased on the company’s website at www.lbcbioscienceinc.com.
Contact Information
Investor Relations
Ten Associates LLC
11529 N. 120th St.
Scottsdale, Arizona
85259 USA
Telephone: 480-326-8577
(0)
(0)
